<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02803970</url>
  </required_header>
  <id_info>
    <org_study_id>2015-08-002</org_study_id>
    <nct_id>NCT02803970</nct_id>
  </id_info>
  <brief_title>KOrean Borderline Ovarian Tumor (KOBOT) Registry</brief_title>
  <acronym>KOBOT</acronym>
  <official_title>Establishing the Registry of Korean Patients With Borderline Ovarian Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kangbuk Samsung Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kangbuk Samsung Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to collect data on Korean patients with borderline ovarian tumors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The researchers retrospectively collected data on Korean patients with borderline ovarian
      tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at
      institutions where placed in the Republic of Korea. And the researchers prospectively will
      collect data on all Korean patients with BOTs at institutions where placed in the Republic of
      Korea since March, 2015. If patients agree to participate in this KOBOT registry, patient's
      data (such as age, body mass index, preoperative findings, laboratory findings, radiologic
      findings, operative findings, pathologic findings, postoperative findings) will be collected
      in a research database. The research database will be updated, every 6 month, to include data
      on patient's disease outcome and follow-up care. Although most data will be collected form
      the medical record, patient may agin be contacted so that researchers can collection some
      data if it is not in the medical record.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 1994</start_date>
  <completion_date type="Anticipated">December 2040</completion_date>
  <primary_completion_date type="Anticipated">December 2040</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Recurrence-free survival</measure>
    <time_frame>up to 100 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Ovarian Neoplasms</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Korean patients with borderline ovarian tumors (BOTs)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed
             between November 1994 and February 2015 at institutions where placed in the Republic
             of Korea.

          -  All patients undergoing gynecologic surgery for BOTs at institutions where placed in
             the Republic of Korea since March, 2015

        Exclusion Criteria:

          -  Patients who did not receive primary treatment or follow-up for at least 6 months at
             each institution were excluded from analysis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taejong Song, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kangbuk Samsung Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Taejong Song, MD,PhD</last_name>
    <phone>82-2-2001-2582</phone>
    <email>taejong.song@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Samsung Changwon Hospital</name>
      <address>
        <city>Changwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Kyu Kim, MD PhD</last_name>
      <phone>821071919285</phone>
      <email>seoulminkyukim@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Min Kyu Kim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03181</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taejong Song</last_name>
      <phone>82-2-2001-2582</phone>
      <email>taejong.song@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Taejong Song, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHA Gangnam Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>06135</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seok Ju Seong, MD, PhD</last_name>
      <phone>821089483124</phone>
      <email>sjseongcheil@naver.com</email>
    </contact>
    <investigator>
      <last_name>Seok Ju Seong, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Byoung-Gie Kim, MD PhD</last_name>
      <phone>82-2-3410-3513</phone>
      <email>bgkim@skku.edu</email>
    </contact>
    <investigator>
      <last_name>Byoung-Gie Kim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2016</study_first_posted>
  <last_update_submitted>September 27, 2016</last_update_submitted>
  <last_update_submitted_qc>September 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kangbuk Samsung Hospital</investigator_affiliation>
    <investigator_full_name>Taejong Song</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

